This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

EU alert to below threshold pharma deals that hurt competition, official says

By Nicholas Hirst ( December 2, 2025, 16:52 GMT | Insight) -- The EU’s antitrust watchdog is keeping an eye out for acquisitions in the pharmaceutical sector that could hurt competition even though they are below the threshold for a merger review, an official has said. Novo Nordisk's failed bid for Metsera was the kind of deal that deserved scrutiny even if it didn't meet notification thresholds, she said.The EU’s antitrust watchdog is keeping an eye out for acquisitions in the pharmaceutical sector that could hurt competition even though they are below the threshold for a merger review, an official said on Tuesday....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login